Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide-Reference-Cited by-同舟云学术

Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide

Published:2022-05 Issue:5 Volume:207 Page:1010-1019
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Pan Alexander¹^ORCID,Reingold Rachel E.¹²^ORCID,Zhao Jimmy L.³,Moy Andrea⁴^ORCID,Kraehenbuehl Lukas¹⁵^ORCID,Dranitsaris George⁶^ORCID,McBride Sean M.⁷,Scher Howard I.³,Kollmeier Marisa A.⁷^ORCID,Xiao Han³,Rathkopf Dana E.³^ORCID,Lacouture Mario E.¹⁸^ORCID

Affiliation:

1. Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

2. Albert Einstein College of Medicine, Bronx, New York

3. Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

4. Dermatopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York

5. Parker Institute for Cancer Immunotherapy, Ludwig Collaborative and Swim Across America Laboratory, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York

6. Department of Public Health, Falk College, Syracuse University, Syracuse, New York

7. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York

8. Department of Dermatology, Weill Cornell Medical College, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000002425

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Identification and Management of Patients with Rash on Apalutamide;Oncology and Therapy;2024-08-01

2. The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies;Critical Reviews in Oncology/Hematology;2024-08

3. Impact of a rash management guide in patients receiving apalutamide for high-risk localized prostate cancer in the Apa-RP study;Prostate Cancer and Prostatic Diseases;2024-07-05

4. Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer;The Prostate;2024-06-18

5. Cutaneous adverse reactions associated to apalumide: two case reports of DRESS syndrome and maculopapular exanthema;Scandinavian Journal of Urology;2024-06-13